Endo Announces FDA Approval of a New Formulation of Opana® ER Designed To Be Crush-Resistant
Created by News on 12/12/2011 8:48:18 AM

Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved a new formulation of Opana® ER designed to be crush-resistant.


CHADDS FORD, Pa., Dec. 12, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has approved a new formulation of Opana® ER designed to be crush-resistant. 

"FDA's approval of this new formulation of Opana ER is an important milestone for both the Long Acting Opioid category as well as Endo's branded pharmaceutical portfolio," said Dr. Ivan Gergel, M.D., executive vice president, R&D and chief scientific officer, Endo Pharmaceuticals. "Patient safety is our top concern and addressing appropriate use of opioids is a responsibility that we take very seriously.  We firmly believe this new formulation of Opana ER, coupled with our long-term commitment to awareness and education around appropriate use of opioids will benefit patients, physicians and payers." 

Endo is committed to executing a seamless transition in 2012 from the original formulation to the new formulation, which utilizes the proprietary INTAC™  technology owned by Grunenthal, a partner in the development of the product.  The new formulation will continue to be called Opana ER with the same dosage strengths, color and packaging and similar tablet size and shape.  Also, the FDA approval signifies that there is no significant difference in the rate and extent of absorption of the therapeutic ingredient between this new formulation and the original formulation of Opana ER. 

Endo also announced that the U.S. Patent and Trademark Office will issue patent number 8,075,872 on Dec. 13, 2011.  The patent covers the new formulation of Opana® ER and is expected to provide protection until November 2023.  This new patent will be listed in the FDA's Orange Book with respect to the new formulation of Opana ER. 

Because Opana ER contains oxymorphone, a CII controlled substance, it remains a Schedule II opioid with all the attendant risks, specifically that the drug has a high potential for abuse. Use, misuse, or abuse of the drug may lead to physical dependence or addiction (addiction is sometimes referred to as "psychological dependence").  In addition, alteration of the tablet in any manner poses significant risks of overdose and death.  It has not been established that this new formulation of Opana ER is less subject to misuse, abuse, diversion, overdose, or addiction.  The Full Prescribing Information contains warnings about the potential for abuse, diversion, overdose and addiction, including a boxed warning (see below).

WARNING: POTENTIAL FOR ABUSE, IMPORTANCE OF PROPER PATIENT SELECTION AND LIMITATIONS OF USE.

See full Prescribing Information for complete boxed warning.

  • Opana® ER contains oxymorphone which is an opioid agonist and a Schedule II controlled substance with an abuse liability similar to other opioid analgesics.
  • Oxymorphone can be abused in a manner similar to other opioid agonists, legal or illicit. This should be considered when prescribing or dispensing Opana® ER in situations where the physician or pharmacist is concerned about an increased risk of misuse, abuse, or diversion.
  • Opana® ER is NOT intended for use as an as needed analgesic.
  • Opana® ER tablets are to be swallowed whole and are not to be broken, chewed, dissolved, or crushed as this leads to rapid release and absorption of a potentially fatal dose of oxymorphone.
  • Patients must not consume alcoholic beverages, prescription or non-prescription medications containing alcohol. Co-ingestion of alcohol with Opana® ER may result in a potentially fatal overdose of oxymorphone.

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments – branded pharmaceuticals, generics and devices and services.  We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries American Medical Systems, HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit http://www.endo.com/.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements.  Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" in our Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein or therein, could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in our Annual Report on Form 10-K. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

SOURCE Endo Pharmaceuticals

print
The comment feature is locked by administrator.
Search News
Top Stories

Apr24 Dental Health Products, Inc. (DHPI) Announces Strategic Alliance with the Dental Exchange
Created by Admin on 4/24/2015 9:24:38 AM

 Dental Health Products, Inc. (DHPI) and The Dental Exchange have announced the formation of a ne...
Read More..

Mar12 Dr. Richard Hughes Named an Honored Fellow of the American Academy of Implant Dentistry
Created by udent webmaster on 3/12/2015 11:04:13 AM

The American Academy of Implant Dentistry (AAID) has named Dr. Richard Hughes an Honored Fellow due ...
Read More..

Mar12 Deerfield Delivers Superior Veterinary Dentistry with Elite Drill
Created by udent webmaster on 3/12/2015 10:41:57 AM

One of Springfield’s leading animal hospitals continues its commitment to providing the best in vete...
Read More..

Mar12 Studio B Dental Launches New Website Specifically for Their All on 4 Dental Implant Procedure
Created by udent webmaster on 3/12/2015 10:39:47 AM

The new website launched by the popular Toronto dental clinic offers a simple 2 minute assessment fo...
Read More..

Mar09 Dr. E. Dale Behner Gives Indianapolis, IN Residents Access to a Minimally Invasive Receding Gums Treatment
Created by udent webmaster on 3/9/2015 10:09:50 PM

Dr. E. Dale Behner of Dental Care Today, PC is expanding his practice to offer help to those with re...
Read More..

Mar09 Growing Emphasis on Prevention of Caries Drives the Global Dental Preventive Supplies Market, According to a New Report by Global Industry Analysts, Inc
Created by udent webmaster on 3/9/2015 10:06:00 PM

Dental caries or tooth decay is one of the major issues for public healthcare systems in most countr...
Read More..

Mar07 Dr. John Schiro DDS Opens New Cosmetic Dentistry Practice in Austin, Texas
Created by udent webmaster on 3/7/2015 4:10:59 PM

Dr. John Schiro DDS is now announcing the grand opening of his new cosmetic dentistry practice in A...
Read More..

Mar20 One Third of Americans Still in Need of Affordable Dental Care Options
Created by Melissa Watkins on 3/20/2014 11:46:00 AM

According to Healthcare.gov, the Health and Human Services arm that is in charge of the federal heal...
Read More..

Feb11 DENTALPLANS.COM CREATES ONLINE PROJECT CENTER FOR NATIONAL CHILDREN’S DENTAL HEALTH MONTH
Created by Melissa Watkins on 2/11/2014 12:50:00 PM

 etting children to brush and floss every day isn’t always easy, especially when parents have a mil...
Read More..

Feb10 126.7 MILLION AMERICANS IN NEED OF DENTAL CARE OPTIONS
Created by Melissa Watkins on 2/10/2014 11:13:00 AM

 As the Affordable Care Act (ACA) discussion switches from accessing the federal and state health e...
Read More..

Jan21 DENTALPLANS.COM APPOINTS BOB HARRIS CHIEF EXECUTIVE OFFICER
Created by Melissa Watkins on 1/21/2014 3:39:00 PM

 entalPlans.com, a leading provider of dental savings plans, has named Bob Harris as chief executiv...
Read More..

Oct16 Keep Your Teeth White !
Created by Mint Cosmetics Review on 10/16/2013 11:58:00 PM

Great plastic is a teeth bleaching package which is prescribed by simply the majority of the dental ...
Read More..

Aug01 Gummy Smiles: What Are My Treatment Options?
Created by mapleavenuefamilydentistry on 8/1/2013 6:29:00 AM

When most people smile, you see a row of teeth that look beautiful and full. Unfortunately, this is ...
Read More..

Jul27 Plastic Surgeons Nj – A Smart Gateway To Beautification
Created by Dr. Michael A. Fiorillo, MD on 7/27/2013 12:05:00 AM

Plastic Surgeons Nj are veterans in the field of plastic surgery. These surgeons can completely cha...
Read More..

Jul22 Dental Implants: Evidence of Modern Dentistry
Created by paul589649 on 7/22/2013 4:50:00 AM

You can find out more about -   Dentist West Hartford CT , Dental Implants West Haven CT , De...
Read More..

Oct22 Guidance of Taking Good Care Of Braces
Created by bonniemendes on 10/22/2012 11:50:00 PM

 Guidance of Taking Good Care Of Braces Finding dependable techniques for taking care of braces as ...
Read More..

Aug13 Periodontist Comments On New Study Examining Diabetes Drug That May Be Able To Fight Oral Cancer
Created by Dr. Alex Farnoosh on 8/13/2012 12:24:00 PM

About The Total Smile: The Total Smile was founded by Beverly Hills Periodontist Dr. Alex Farn...
Read More..

Jul17 360imaging releases an improved version 4 of 360DPS dental implant planning software
Created by Manal on 7/17/2012 4:25:00 AM

 360 Imaging – an industry leader in dental implant planning - recently announced the release of  v...
Read More..

Jul11 iCare Financial Launches Strategic Alliance With Concorde Communications To Benefit Growth Of Dental Practices
Created by iCare Credit on 7/11/2012 4:28:00 PM

iCare Financial, a leading provider of patient credit, and Concorde Communications, an acclaimed me...
Read More..

Jun26 Periodontist Discusses Study Linking Osteoporosis Drug Complications To Patients With Certain Genes
Created by Dr. Alex Farnoosh on 6/26/2012 10:14:00 AM

On the heels of an earlier study linking antiresorptive drugs to medication induced osteonecrosis...
Read More..